Bajaj Prem, Arendt-Nielsen Lars, Madeleine Pascal, Svensson Peter
Laboratory for Experimental Pain Research, Centre for Sensory-Motor Interaction, Fredrick Bajers VEJ 7 D3, Aalborg University, Denmark DK-9220.
Eur J Pain. 2003;7(5):407-18. doi: 10.1016/S1090-3801(02)00145-3.
The role of tolperisone hydrochloride, a centrally acting muscle relaxant in relieving painful muscle spasm is recently being discussed. The present study hypothesizes that the prophylactic use of tolperisone hydrochloride may effectively relieve post-exercise muscle soreness, based on the spasm theory of exercise pain. Twenty male volunteers, aged 25.2 +/- 0.82 years (mean +/- SEM) participated in 10 sessions in which they received oral treatment with placebo or the centrally acting muscle relaxant tolperisone hydrochloride (150 mg) three times daily for 8 days, in randomized crossover double-blind design. Time course assessments were made for pressure pain threshold, Likert's pain score (0-5), pain areas, range of abduction, isometric force, and electromyography (EMG) root mean square (RMS) during maximum voluntary isometric force on day 1 and 6, immediately after an eccentric exercise of first dorsal interosseous muscle, and 24 and 48 h after the exercise. Treatment with placebo or tolperisone hydrochloride was initiated immediately after the assessments on the first day baseline assessments. On the sixth day baseline investigations were repeated and then the subjects performed six bouts of standardized intense eccentric exercise of first dorsal interosseous muscle for provocation of post-exercise muscle soreness (PEMS). Perceived intensity of warmth, tiredness, soreness and pain during the exercise bouts were recorded on a 10 cm visual analogue pain scale. VAS scores and pressure pain thresholds did not differ between tolperisone and placebo treatment. All VAS scores increased during the exercise bouts 2, 3, 4, 5 and 6 as compared to bout 1. Increased pain scores and pain areas were reported immediately after, 24 and 48 h after exercise. Pressure pain thresholds were reduced at 24 and 48 h after the exercise in the exercised hand. Range of abduction of the index finger was reduced immediately after the exercise and was still reduced at 24 h as compared to the non-exercised hand. The EMG RMS amplitude was also reduced immediately after the exercise, but was increased at 24 and 48 h. Isometric force was reduced immediately after the exercise as compared to days 1, 6, and the 24 and 48 h post-exercise assessments with a greater reduction following the tolperisone hydrochloride treatment and the reduction was more in tolperisone group as compared to the placebo group. The results suggest, that the prophylactic intake of tolperisone hydrochloride provides no relief to pain in course of post-exercise muscle soreness but results in reduction in isometric force.
近来,人们对中枢性肌肉松弛剂盐酸托哌酮在缓解疼痛性肌肉痉挛方面的作用展开了讨论。本研究基于运动性疼痛的痉挛理论提出假设,即预防性使用盐酸托哌酮可能有效缓解运动后肌肉酸痛。20名年龄在25.2±0.82岁(均值±标准误)的男性志愿者参与了10次试验,试验采用随机交叉双盲设计,他们接受了为期8天的口服治疗,每日3次,分别服用安慰剂或中枢性肌肉松弛剂盐酸托哌酮(150毫克)。在第1天和第6天,于第一背侧骨间肌进行离心运动后即刻、运动后24小时和48小时,在最大自主等长力期间,对压力痛阈、李克特疼痛评分(0 - 5)、疼痛区域、外展范围、等长力和肌电图(EMG)均方根(RMS)进行了时间进程评估。在第一天的基线评估后立即开始使用安慰剂或盐酸托哌酮治疗。在第六天重复进行基线调查,然后受试者进行6组标准化的第一背侧骨间肌剧烈离心运动以诱发运动后肌肉酸痛(PEMS)。在10厘米视觉模拟疼痛量表上记录运动组期间的热感、疲劳感、酸痛感和疼痛感。盐酸托哌酮组和安慰剂组的视觉模拟评分(VAS)和压力痛阈没有差异。与第1组相比,在第2、3、4、5和6组运动期间所有VAS评分均升高。运动后即刻、24小时和48小时报告疼痛评分和疼痛区域增加。运动后24小时和48小时,运动手的压力痛阈降低。运动后即刻食指外展范围减小,与未运动手相比,24小时时仍减小。运动后即刻肌电图RMS幅度也降低,但在24小时和48小时时升高。与第1天、第6天以及运动后24小时和48小时的评估相比,运动后即刻等长力降低,盐酸托哌酮治疗后降低幅度更大,且与安慰剂组相比,盐酸托哌酮组降低幅度更大。结果表明,预防性摄入盐酸托哌酮并不能缓解运动后肌肉酸痛过程中的疼痛,但会导致等长力降低。